Targeting Complement C3a Receptor to Improve Outcome After Ischemic Brain InjuryMarcela Pekna(University of Gothenburg), Milos Pekny(Florey Institute of Neuroscience and Mental Health)Neurochemical ResearchAugust 11, 202110.1007/s11064-021-03419-6Cited by 36SaveCiteExport RISWatch citationsRelated PapersComplement-Derived Anaphylatoxin C3a Regulates In Vitro Differentiation and Migration of Neural Progenitor Cells|Stem Cells|2009|167Vimentin Phosphorylation Is Required for Normal Cell Division of Immature Astrocytes|Cells|2019|22